A survey of medical cannabis patients combined with chemical analysis found that THC and the terpene trans-nerolidol correlated with anxiety relief, while several other terpenes (guaiol, eucalyptol, and others) correlated with reduced effectiveness.
Medical cannabis patients using cannabis for anxiety; dispensary staff guiding strain selection; cannabis researchers studying the entourage effect.
Patients rated cannabis 8.03/10 for anxiety relief; THC and trans-nerolidol linked to effectiveness
What the researchers found
Medical cannabis patients receiving organically grown cannabis from a single source rated cannabis as highly effective for anxiety (average 8.03 out of 10 on a Likert scale).
Patients identified which strains they found most and least effective for anxiety. The top four and bottom four strains were then chemically analyzed by HPLC-MS/MS (for cannabinoids) and GC-MS (for terpenes).
THC and trans-nerolidol showed statistically significant correlations with increased anxiety relief.
Six terpenes correlated with decreased anxiety relief: guaiol, eucalyptol, γ-terpinene, α-phellandrene, 3-carene, and sabinene hydrate.
The findings support the "entourage effect" hypothesis, suggesting that the therapeutic profile of cannabis for anxiety depends on the specific combination of cannabinoids and terpenes, not just THC or CBD levels alone.
Why it matters
Most cannabis-for-anxiety research focuses on THC and CBD. This study takes a systems approach, analyzing terpene profiles alongside cannabinoids to identify which chemical signatures are associated with anxiety relief. This could eventually help guide strain selection for patients.
The numbers in context
Average anxiety relief rating: 8.03/10. THC and trans-nerolidol positively correlated with anxiolytic activity (statistically significant). Six terpenes negatively correlated: guaiol, eucalyptol, γ-terpinene, α-phellandrene, 3-carene, sabinene hydrate.
How the study worked
Patient survey combined with chemical analysis. Medical cannabis patients rated strain effectiveness for anxiety. Top and bottom strains analyzed by HPLC-MS/MS (cannabinoids) and GC-MS (terpenes). Statistical correlations between chemical profiles and patient-reported effectiveness.
What this study cannot tell us
Small number of strains analyzed (top 4 and bottom 4). Patient self-report is subjective and susceptible to expectation effects. Single-source cannabis limits generalizability. Correlational design cannot establish which compounds are causing the effects.
How to read the evidence
Preliminary. Novel approach combining patient reports with chemical analysis, but small sample of strains and correlational design limit strength.
When this study was published
Published in 2018. Research on cannabis terpenes and the entourage effect has expanded since, though controlled trials remain rare.
The bigger picture
This represents early steps toward understanding why different cannabis strains produce different therapeutic effects. If specific terpene-cannabinoid combinations can be reliably linked to anxiety relief, this could move medical cannabis beyond the "indica vs. sativa" framework toward chemotype-based prescribing.
Questions still open
- Does trans-nerolidol directly contribute to anxiety relief or is it a marker for another active compound? Would controlled trials with specific terpene-cannabinoid combinations confirm these correlations? How consistent are terpene profiles across different grows of the same strain?
Common questions
What is trans-nerolidol?
What is the entourage effect?
Read the original research
Cannabis and the Anxiety of Fragmentation-A Systems Approach for Finding an Anxiolytic Cannabis Chemotype.
Frontiers in neuroscience, 12, 730
Citation
Kamal, Brishna S; Kamal, Fatima; Lantela, Daniel E. (2018). Cannabis and the Anxiety of Fragmentation-A Systems Approach for Finding an Anxiolytic Cannabis Chemotype.. Frontiers in neuroscience, 12, 730. https://doi.org/10.3389/fnins.2018.00730
Explore the wider topic
- Weed Withdrawal Anxiety in Public: When Leaving the House Feels Impossible
- The DARE Response to Anxiety for Cannabis Withdrawal
- The Cannabis Withdrawal Anxiety Toolkit: Quick Techniques That Work
- Why Anxiety Gets Worse Before It Gets Better After Quitting Weed
- Breathing Exercises for Weed Withdrawal Anxiety
- Cannabis-Induced Anxiety: When Weed Stops Being Fun
- Does Weed Help or Hurt Anxiety? What Research Actually Shows
- Grounding Techniques for Cannabis Withdrawal: A Practical Toolkit
- Quitting Weed with Health Anxiety: Why Every Symptom Feels Like a Crisis
- How to Manage Anxiety Without Weed: 15 Evidence-Based Alternatives
- Quitting Weed with Anxiety Disorder: A Careful Approach
- Quitting Weed When You're on Anxiety Medication: What to Know
- Self-Medicating Anxiety with Weed: Why It Works Until It Doesn't
- Do I Need Therapy to Quit Weed? When Professional Help Makes Sense
- Weed and Anxiety: The Paradox That Traps People
- The Biphasic Effect: Low-Dose Calms, High-Dose Panics
- Weed and Generalized Anxiety Disorder (GAD): Why It Backfires
- Weed and Panic Attacks: The Connection Nobody Talks About
- Weed and Paranoia: When Cannabis Turns Your Mind Against You
- Weed and Social Anxiety: Why It Feels Like the Only Thing That Helps
- Why Weed Stopped Working for Your Anxiety
- Weed Withdrawal Anxiety: Understanding the Panic and How to Cope
- Weed Withdrawal Panic Attacks at Night: Why They Happen and How to Get Through Them
- Going Back to Work During Weed Withdrawal: Managing Anxiety and Staying Functional
- Withdrawal Anxiety vs Pre-Existing Anxiety: How to Tell the Difference